This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignee: Cytonet Gmbh & Co. Kg. Active years: 2015-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2018
Title: Lubomir Arseniev: Innovator in Cell Suspension Preparation
Introduction
Lubomir Arseniev is a notable inventor based in Hannover, Germany. He has made significant contributions to the field of biotechnology, particularly in the preparation of disinfected human cell suspensions. With a total of 2 patents, his work has implications for medical and research applications.
Latest Patents
Arseniev's latest patents focus on a process for the preparation of disinfected human cell suspensions. This innovative process involves perfusing mammalian tissue with an enzyme-free liquid antibiotic composition that contains at least one antibiotic and is included in a perfusion buffer. Following this step, an enzymatic antibiotic-free treatment is performed to obtain a single-cell suspension. The final step results in the production of disinfected preparations, showcasing his expertise in tissue processing.
Career Highlights
Throughout his career, Lubomir Arseniev has worked with prominent companies in the biotechnology sector. Notable among these are Cytonet GmbH & Co. KG and Promethera Biosciences S.A./N.V. His experience in these organizations has allowed him to refine his skills and contribute to advancements in cell suspension technologies.
Collaborations
Arseniev has collaborated with several professionals in his field, including Krasimira Aleksandrova and Marc Barthold. These partnerships have likely enriched his research and development efforts, fostering innovation in his projects.
Conclusion
Lubomir Arseniev stands out as an influential inventor in the biotechnology industry, particularly with his innovative processes for preparing disinfected human cell suspensions. His contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile